Active GSK3β binds to CK1 (Casein Kinase 1), APC (Adenomatous Polyposis Coli), AXIN1 and other members of the destruction complex to inhibit tumor development by phosphorylation and subsequent degradation of the oncogenic β-catenin protein (35). This evidence concerns the gene GSK3B and neoplasm.